Readmissions Within 48 Hours of Discharge: Reasons, Risk Factors, and Potential Improvements.


Journal

Diseases of the colon and rectum
ISSN: 1530-0358
Titre abrégé: Dis Colon Rectum
Pays: United States
ID NLM: 0372764

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 19 12 2020
Statut: ppublish

Résumé

Hospital readmission rate is an important quality metric and has been recognized as a key measure of hospital value-based purchasing programs. This study aimed to assess the risk factors for hospital readmission with a focus on potentially preventable early readmissions within 48 hours of discharge. This is a retrospective cohort study. This study was conducted at a tertiary academic facility with a standardized enhanced recovery pathway. Consecutive patients undergoing elective major colorectal resections between 2011 and 2016 were included. Univariable and multivariable risk factors for overall and early (<48 hours) readmissions were identified. Specific surgical and medical reasons for readmission were compared between early and late readmissions. In total, 526 of 4204 patients (12.5%) were readmitted within 30 days of discharge. Independent risk factors were ASA score (≥3; OR, 1.5; 95% CI, 1.1-2), excess perioperative weight gain (OR, 1.7; 95% CI, 1.3-2.3), ileostomy (OR, 1.4; 95% CI, 1-2), and transfusion (OR, 2; 95% CI, 1.4-3), or reoperation (OR, 11.4; 95% CI, 7.4-17.5) during the index stay. No potentially preventable risk factor for early readmission (128 patients, 24.3% of all readmissions, 3% of total cohort) was identified, and index hospital stay of ≤3 days was not associated with increased readmission (OR, 0.9; 95% CI, 0.7-1.2). Although ileus and small-bowel obstruction (early: 43.8% vs late: 15.5%, p < 0.001) were leading causes for early readmissions, deep infections (3.9% vs 16.3%, p < 0.001) and acute kidney injury (0% vs 5%, p = 0.006) were mainly observed during readmissions after 48 hours. Risk of underreporting due to loss of follow-up and the potential co-occurrence of complications were limitations of this study. Early hospital readmission was mainly due to ileus or bowel obstruction, whereas late readmissions were related to deep infections and acute kidney injury. A suspicious attitude toward potential ileus-related symptoms before discharge and dedicated education for ostomy patients are important. A short index hospital stay was not associated with increased readmission rates. See Video Abstract at http://links.lww.com/DCR/B237. REINGRESOS DENTRO DE LAS 48 HORAS POSTERIORES AL ALTA: RAZONES, FACTORES DE RIESGO Y POSIBLES MEJORAS: La tasa de reingreso hospitalario es una métrica de calidad importante y ha sido reconocida como una medida clave de los programas hospitalarios de compras basadas en el valor.Evaluar los factores de riesgo para el reingreso hospitalario con énfasis en reingresos tempranos potencialmente prevenibles dentro de las 48 horas posteriores al alta.Estudio de cohorte retrospectivo.Institución académica terciaria con programa de recuperación mejorada estandarizado.Pacientes consecutivos sometidos a resecciones colorrectales mayores electivas entre 2011 y 2016.Se identificaron factores de riesgo uni y multivariables para reingresos totales y tempranos (<48 horas). Se compararon razones médicas y quirúrgicas específicas para el reingreso entre reingresos tempranos y tardíos.En total, 526/4204 pacientes (12,5%) fueron readmitidos dentro de los 30 días posteriores al alta. Los factores de riesgo independientes fueron puntuación ASA (≥3, OR 1.5; IC 95% 1.1-2), aumento de peso perioperatorio excesivo (OR 1.7; IC 95% 1.3-2.3), ileostomía (OR 1.4, IC 95%: 1-2) y transfusión (OR 2, IC 95% 1.4-3) o reoperación (OR 11.4; IC 95% 7.4-17.5) durante la estadía índice. No se identificó ningún factor de riesgo potencialmente prevenible para el reingreso temprano (128 pacientes, 24.3% de todos los reingresos, 3% de la cohorte total), y la estadía hospitalaria índice de ≤ 3 días no se asoció con un aumento en el reingreso (OR 0.9; IC 95% 0.7-1.2) Mientras que el íleo / obstrucción del intestino delgado (temprano: 43.8% vs. tardío: 15.5%, p < 0.001) fueron las principales causas de reingresos tempranos, infecciones profundas (3.9% vs 16.3%, p < 0.001) y lesión renal aguda (0 vs 5%, p = 0.006) se observaron principalmente durante los reingresos después de 48 horas.Riesgo de subregistro debido a la pérdida en el seguimiento, posible co-ocurrencia de complicaciones.El reingreso hospitalario temprano se debió principalmente a íleo u obstrucción intestinal, mientras que los reingresos tardíos se relacionaron con infecciones profundas y lesión renal aguda. Es importante tener una actitud suspicaz hacia los posibles síntomas relacionados con el íleo antes del alta y una educación específica para los pacientes con ostomía. La estadía hospitalaria índice corta no se asoció con mayores tasas de reingreso. Consulte Video Resumen en http://links.lww.com/DCR/B237.

Sections du résumé

BACKGROUND
Hospital readmission rate is an important quality metric and has been recognized as a key measure of hospital value-based purchasing programs.
OBJECTIVE
This study aimed to assess the risk factors for hospital readmission with a focus on potentially preventable early readmissions within 48 hours of discharge.
DESIGN
This is a retrospective cohort study.
SETTINGS
This study was conducted at a tertiary academic facility with a standardized enhanced recovery pathway.
PATIENTS
Consecutive patients undergoing elective major colorectal resections between 2011 and 2016 were included.
MAIN OUTCOME MEASURES
Univariable and multivariable risk factors for overall and early (<48 hours) readmissions were identified. Specific surgical and medical reasons for readmission were compared between early and late readmissions.
RESULTS
In total, 526 of 4204 patients (12.5%) were readmitted within 30 days of discharge. Independent risk factors were ASA score (≥3; OR, 1.5; 95% CI, 1.1-2), excess perioperative weight gain (OR, 1.7; 95% CI, 1.3-2.3), ileostomy (OR, 1.4; 95% CI, 1-2), and transfusion (OR, 2; 95% CI, 1.4-3), or reoperation (OR, 11.4; 95% CI, 7.4-17.5) during the index stay. No potentially preventable risk factor for early readmission (128 patients, 24.3% of all readmissions, 3% of total cohort) was identified, and index hospital stay of ≤3 days was not associated with increased readmission (OR, 0.9; 95% CI, 0.7-1.2). Although ileus and small-bowel obstruction (early: 43.8% vs late: 15.5%, p < 0.001) were leading causes for early readmissions, deep infections (3.9% vs 16.3%, p < 0.001) and acute kidney injury (0% vs 5%, p = 0.006) were mainly observed during readmissions after 48 hours.
LIMITATIONS
Risk of underreporting due to loss of follow-up and the potential co-occurrence of complications were limitations of this study.
CONCLUSIONS
Early hospital readmission was mainly due to ileus or bowel obstruction, whereas late readmissions were related to deep infections and acute kidney injury. A suspicious attitude toward potential ileus-related symptoms before discharge and dedicated education for ostomy patients are important. A short index hospital stay was not associated with increased readmission rates. See Video Abstract at http://links.lww.com/DCR/B237. REINGRESOS DENTRO DE LAS 48 HORAS POSTERIORES AL ALTA: RAZONES, FACTORES DE RIESGO Y POSIBLES MEJORAS: La tasa de reingreso hospitalario es una métrica de calidad importante y ha sido reconocida como una medida clave de los programas hospitalarios de compras basadas en el valor.Evaluar los factores de riesgo para el reingreso hospitalario con énfasis en reingresos tempranos potencialmente prevenibles dentro de las 48 horas posteriores al alta.Estudio de cohorte retrospectivo.Institución académica terciaria con programa de recuperación mejorada estandarizado.Pacientes consecutivos sometidos a resecciones colorrectales mayores electivas entre 2011 y 2016.Se identificaron factores de riesgo uni y multivariables para reingresos totales y tempranos (<48 horas). Se compararon razones médicas y quirúrgicas específicas para el reingreso entre reingresos tempranos y tardíos.En total, 526/4204 pacientes (12,5%) fueron readmitidos dentro de los 30 días posteriores al alta. Los factores de riesgo independientes fueron puntuación ASA (≥3, OR 1.5; IC 95% 1.1-2), aumento de peso perioperatorio excesivo (OR 1.7; IC 95% 1.3-2.3), ileostomía (OR 1.4, IC 95%: 1-2) y transfusión (OR 2, IC 95% 1.4-3) o reoperación (OR 11.4; IC 95% 7.4-17.5) durante la estadía índice. No se identificó ningún factor de riesgo potencialmente prevenible para el reingreso temprano (128 pacientes, 24.3% de todos los reingresos, 3% de la cohorte total), y la estadía hospitalaria índice de ≤ 3 días no se asoció con un aumento en el reingreso (OR 0.9; IC 95% 0.7-1.2) Mientras que el íleo / obstrucción del intestino delgado (temprano: 43.8% vs. tardío: 15.5%, p < 0.001) fueron las principales causas de reingresos tempranos, infecciones profundas (3.9% vs 16.3%, p < 0.001) y lesión renal aguda (0 vs 5%, p = 0.006) se observaron principalmente durante los reingresos después de 48 horas.Riesgo de subregistro debido a la pérdida en el seguimiento, posible co-ocurrencia de complicaciones.El reingreso hospitalario temprano se debió principalmente a íleo u obstrucción intestinal, mientras que los reingresos tardíos se relacionaron con infecciones profundas y lesión renal aguda. Es importante tener una actitud suspicaz hacia los posibles síntomas relacionados con el íleo antes del alta y una educación específica para los pacientes con ostomía. La estadía hospitalaria índice corta no se asoció con mayores tasas de reingreso. Consulte Video Resumen en http://links.lww.com/DCR/B237.

Identifiants

pubmed: 32692075
doi: 10.1097/DCR.0000000000001652
pii: 00003453-202008000-00018
doi:

Types de publication

Journal Article Webcast

Langues

eng

Sous-ensembles de citation

IM

Pagination

1142-1150

Références

Greer NL, Gunnar WP, Dahm P, et al.enhanced recovery protocols for adults undergoing colorectal surgery: a systematic review and meta-analysis. Dis Colon Rectum. 2018;61:1108–1118.
Greco M, Capretti G, Beretta L, Gemma M, Pecorelli N, Braga MEnhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials. World J Surg. 2014;38:1531–1541.
Zhuang CL, Ye XZ, Zhang XD, Chen BC, Yu ZEnhanced recovery after surgery programs versus traditional care for colorectal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2013;56:667–678.
Bliss LA, Maguire LH, Chau Z, et al.Readmission after resections of the colon and rectum: predictors of a costly and common outcome. Dis Colon Rectum. 2015;58:1164–1173.
Al-Mazrou AM, Suradkar K, Mauro CM, Kiran RPCharacterization of readmission by day of rehospitalization after colorectal surgery. Dis Colon Rectum. 2017;60:202–212.
Bartlett EK, Hoffman RL, Mahmoud NN, Karakousis GC, Kelz RRPostdischarge occurrences after colorectal surgery happen early and are associated with dramatically increased rates of readmission. Dis Colon Rectum. 2014;57:1309–1316.
Brauer DG, Lyons SA, Keller MR, Mutch MG, Colditz GA, Glasgow SCSimplified risk prediction indices do not accurately predict 30-day death or readmission after discharge following colorectal surgery. Surgery. 2019;165:882–888.
Rattan R, Parreco J, Lindenmaier LB, et al.Underestimation of unplanned readmission after colorectal surgery: a national analysis. J Am Coll Surg. 2018;226:382–390.
Larson DW, Lovely JK, Cima RR, et al.Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery. Br J Surg. 2014;101:1023–1030.
Lovely JK, Maxson PM, Jacob AK, et al.Case-matched series of enhanced versus standard recovery pathway in minimally invasive colorectal surgery. Br J Surg. 2012;99:120–126.
Khreiss W, Huebner M, Cima RR, et al.Improving conventional recovery with enhanced recovery in minimally invasive surgery for rectal cancer. Dis Colon Rectum. 2014;57:557–563.
Grass F, Lovely JK, Crippa J, Mathis KL, Hübner M, Larson DWEarly acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg. 2019;43:1207–1215.
Lovely JK, Larson DW, Quast JMA clinical practice agreement between pharmacists and surgeons streamlines medication management. Jt Comm J Qual Patient Saf. 2014;40:296–302.
Thiele RH, Raghunathan K, Brudney CS, et alPerioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med (Lond). 2016;5:24.
Hübner M, Lovely JK, Huebner M, Slettedahl SW, Jacob AK, Larson DWIntrathecal analgesia and restrictive perioperative fluid management within enhanced recovery pathway: hemodynamic implications. J Am Coll Surg. 2013;216:1124–1134.
Grass F, Hübner M, Lovely JK, Crippa J, Mathis KL, Larson DWOrdering a normal diet at the end of surgery-justified or overhasty? Nutrients. 2018;10:1758.
Emori TG, Culver DH, Horan TC, et al.National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control. 1991;19:19–35.
Merchea A, Lovely JK, Jacob AK, et al.Efficacy and outcomes of intrathecal analgesia as part of an enhanced recovery pathway in colon and rectal surgical patients. Surg Res Pract. 2018;2018:8174579.
Lemini R, Spaulding AC, Naessens JM, et al.ERAS protocol validation in a propensity-matched cohort of patients undergoing colorectal surgery. Int J Colorectal Dis. 2018;33:1543–1550.
Dindo D, Demartines N, Clavien PAClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
Berian JR, Ban KA, Liu JB, Ko CY, Feldman LS, Thacker JKAdherence to enhanced recovery protocols in NSQIP and association with colectomy outcomes. Ann Surg. 2019;269:486–493.
Favini N, Hockenberry JM, Gilman M, et al.Comparative trends in payment adjustments between safety-net and other hospitals since the introduction of the Hospital Readmission Reduction Program and value-based purchasing. JAMA. 2017;317:1578–1580.
Joynt KE, Figueroa JE, Oray J, Jha AKOpinions on the Hospital Readmission Reduction Program: results of a national survey of hospital leaders. Am J Manag Care. 2016;22:e287–e294.
Mehtsun WT, Papanicolas I, Zheng J, Orav EJ, Lillemoe KD, Jha AKNational trends in readmission following inpatient surgery in the Hospital Readmissions Reduction Program era. Ann Surg. 2018;267:599–605.
Wick EC, Shore AD, Hirose K, et al.Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011;54:1475–1479.
Damle RN, Cherng NB, Flahive JM, et al.Clinical and financial impact of hospital readmissions after colorectal resection: predictors, outcomes, and costs. Dis Colon Rectum. 2014;57:1421–1429.
Zafar SN, Shah AA, Channa H, Raoof M, Wilson L, Wasif NComparison of rates and outcomes of readmission to index vs nonindex hospitals after major cancer surgery. JAMA Surg. 2018;153:719–727.
Bennedsen ALB, Eriksen JR, Gögenur IProlonged hospital stay and readmission rate in an enhanced recovery after surgery cohort undergoing colorectal cancer surgery. Colorectal Dis. 2018;20:1097–1108.
Turina M, Remzi FH, Dietz DW, et al.Quantification of risk for early unplanned readmission after rectal resection: a single-center study. J Am Coll Surg. 2013;217:200–208.
Lucas DJ, Haider A, Haut E, et al.Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. Ann Surg. 2013;258:430–439.
Venara A, Alfonsi P, Cotte E, Loriau J, Hamel JF, Slim KFrancophone Group for Enhanced Recovery After Surgery (GRACE). Correction to: Postoperative ileus concealing intra-abdominal complications in enhanced recovery programs-a retrospective analysis of the GRACE database. Int J Colorectal Dis. 2019;34:1509–1514.
Wood T, Aarts MA, Okrainec A, et aliERAS group. Emergency room visits and readmissions following Implementation of an Enhanced Recovery After Surgery (iERAS) program. J Gastrointest Surg. 2018;22:259–266.
Venara A, Neunlist M, Slim K, et al.Postoperative ileus: pathophysiology, incidence, and prevention. J Visc Surg. 2016;153:439–446.
Grass F, Martin D, Moulin E, Hahnloser D, Demartines N, Hübner MSpecific national surveillance program for organ space infections after colonic surgery. Surg Infect (Larchmt). 2019;20:373–377.
Martin D, Hübner M, Moulin E, et al.Timing, diagnosis, and treatment of surgical site infections after colonic surgery: prospective surveillance of 1263 patients. J Hosp Infect. 2018;100:393–399.
Shah PM, Johnston L, Sarosiek B, et al.Reducing readmissions while shortening length of stay: the positive impact of an enhanced recovery protocol in colorectal surgery. Dis Colon Rectum. 2017;60:219–227.
Lawrence JK, Keller DS, Samia H, et al.Discharge within 24 to 72 hours of colorectal surgery is associated with low readmission rates when using Enhanced Recovery Pathways. J Am Coll Surg. 2013;216:390–394.

Auteurs

Fabian Grass (F)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.
Department of Visceral Surgery, Lausanne University Hospital CHUV, Lausanne, Switzerland.

Jacopo Crippa (J)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Jenna K Lovely (JK)

Hospital Pharmacy Services, Mayo Clinic, Rochester, Minnesota.

James Ansell (J)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Kevin T Behm (KT)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Pietro Achilli (P)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Martin Hübner (M)

Department of Visceral Surgery, Lausanne University Hospital CHUV, Lausanne, Switzerland.

Scott R Kelley (SR)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Kellie L Mathis (KL)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Eric J Dozois (EJ)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

David W Larson (DW)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH